ARCH Venture Fund VIII L.P. 13D and 13G filings for Denali Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-08 3:04 pm Sale |
2021-12-31 | 13G | Denali Therapeutics Inc. DNLI |
ARCH Venture Fund VIII L.P. | 0 0.000% |
-10,735,948 (Position Closed) |
Filing |
| 2021-02-02 5:04 pm Purchase |
2020-12-31 | 13G | Denali Therapeutics Inc. DNLI |
ARCH Venture Fund VIII L.P. | 10,735,948 9.000% |
37,339 (+0.35%) |
Filing |